There are no contraindications for Calquence. Lumakras is an inhibitor of the RAS GTPase family. The recommended dose of Lumakras in combination with panitumumab for mCRC is 960 mg orally once ...

The BIPA amendment at issue—which went into effect on August 2, 2024—created a new limitation on liability. Originally, BIPA (as interpreted by the Illinois Supreme Court) provided statutory ...

These compounds show strong therapeutic potential. KRAS (Kirsten Rat Sarcoma Viral Oncogene Homologue) is a small GTPase protein that regulates cell growth and survival through the mitogen-activated ...

In doing so, it will contribute to the growth of the UK economy by helping businesses make better decisions.” Patrick Walsh, Chair of the Business Informational Providers Association (BIPA), said: ...